Kolon Life Science Decides on 20 Billion KRW Paid-in Capital Increase... Kolon Third-Party Allocation

KOSDAQ-listed company Kolon Life Science announced on the 13th that it has decided to conduct a third-party allotment paid-in capital increase to raise 20 billion KRW for operating funds and other purposes.

New shares amounting to 919,120 common shares will be issued at 21,760 KRW per share. The third-party allotment recipient is Kolon (majority shareholder, 919,120 shares).